Search is on for cases of aggressive, ruxolitinib-associated skin cancers

ORLANDO – The hematologic cancer drug ruxolitinib seems to be associated with cases of aggressive nonmelanoma skin cancer. After treating a very aggressive squamous cell carcinoma in a 55-year-old man treated with ruxolitinib for polycythemia vera, and hearing firsthand of three other similar...
Source: Skin and Allergy News - Category: Dermatology Source Type: news